BHB
DXCM icon

Bank Hapoalim BM’s DexCom DXCM Stock Holding History

Bank Hapoalim BM’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,992
Closed -$267K – 205
2021
Q4 		$267K Sell
1,992
-420
-17% -$60.4K 0.03% 215
2021
Q3 		$330K Sell
2,412
-40
-2% -$5.04K 0.03% 199
2021
Q2 		$262K Sell
2,452
-644
-21% -$61.8K 0.03% 220
2021
Q1 		$278K Hold
3,096
– – 0.04% 203
2020
Q4 		$286K Hold
3,096
– – 0.04% 174
2020
Q3 		$319K Sell
3,096
-440
-12% -$46K 0.01% 142
2020
Q2 		$358K Sell
3,536
-320
-8% -$28.6K 0.08% 136
2020
Q1 		$260K Sell
3,856
-2,464
-39% -$153K 0.08% 142
2019
Q4 		$346K Hold
6,320
– – 0.08% 132
2019
Q3 		$235K Sell
6,320
-260
-4% -$10.1K 0.06% 147
2019
Q2 		$246K Buy
+6,580
New +$207K 0.06% 148

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bank Hapoalim BM's DXCM Position: Q1 2022 in Review

Bank Hapoalim BM sold out of DexCom (DXCM) in Q1 2022, closing a stake of 1,992 shares — an estimated $267K sold.

Bank Hapoalim BM first reported a position in DXCM in Q2 2019 and held it in 11 quarters. The position peaked at $358K in Q2 2020. 862 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

  • Bank Hapoalim BM reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
  • Bank Hapoalim BM sold 1,992 DexCom shares in Q1 2022, an estimated $267K.
  • Bank Hapoalim BM first reported a position in DexCom in Q2 2019 and held it in 11 quarters.
  • Bank Hapoalim BM's DexCom position peaked at $358K in Q2 2020.
  • 862 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Bank Hapoalim BM's 13F filing for Q1 2022, filed 28 Apr 2022.